Concepts (247)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder, Neurogenic | 1 | 2023 | 45 | 0.840 |
Why?
|
| Carcinoma, Renal Cell | 9 | 2006 | 235 | 0.830 |
Why?
|
| Bacteriuria | 1 | 2023 | 82 | 0.790 |
Why?
|
| Kidney Neoplasms | 10 | 2006 | 426 | 0.770 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2023 | 166 | 0.720 |
Why?
|
| Vesico-Ureteral Reflux | 5 | 2023 | 77 | 0.680 |
Why?
|
| Ureteral Obstruction | 4 | 2023 | 108 | 0.650 |
Why?
|
| Urinary Tract Infections | 1 | 2023 | 289 | 0.640 |
Why?
|
| Cryosurgery | 4 | 2005 | 47 | 0.580 |
Why?
|
| Ureter | 4 | 2023 | 96 | 0.580 |
Why?
|
| Nephrectomy | 4 | 2018 | 172 | 0.550 |
Why?
|
| Kidney Pelvis | 3 | 2021 | 43 | 0.490 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2016 | 202 | 0.460 |
Why?
|
| Hypospadias | 3 | 2020 | 81 | 0.440 |
Why?
|
| Kidney | 2 | 2016 | 1340 | 0.400 |
Why?
|
| Neonatal Screening | 3 | 2008 | 187 | 0.350 |
Why?
|
| Adrenal Hyperplasia, Congenital | 2 | 2008 | 34 | 0.350 |
Why?
|
| Urology | 2 | 2018 | 73 | 0.350 |
Why?
|
| Serum | 1 | 2010 | 45 | 0.340 |
Why?
|
| Blood Specimen Collection | 1 | 2010 | 46 | 0.340 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 2030 | 0.340 |
Why?
|
| Blood Chemical Analysis | 1 | 2010 | 77 | 0.330 |
Why?
|
| Carbon | 1 | 2010 | 90 | 0.330 |
Why?
|
| Prostate | 2 | 2017 | 422 | 0.320 |
Why?
|
| Urethral Diseases | 2 | 2020 | 16 | 0.310 |
Why?
|
| Postoperative Complications | 5 | 2023 | 2997 | 0.310 |
Why?
|
| Bile Acids and Salts | 1 | 2010 | 235 | 0.290 |
Why?
|
| Cortodoxone | 1 | 2007 | 2 | 0.290 |
Why?
|
| 17-alpha-Hydroxyprogesterone | 1 | 2007 | 5 | 0.290 |
Why?
|
| Penis | 2 | 2020 | 96 | 0.280 |
Why?
|
| Laparoscopy | 4 | 2018 | 502 | 0.280 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2005 | 7 | 0.250 |
Why?
|
| Kidney Transplantation | 2 | 2023 | 621 | 0.250 |
Why?
|
| Catheter Ablation | 2 | 2005 | 229 | 0.250 |
Why?
|
| Retrospective Studies | 15 | 2023 | 15853 | 0.240 |
Why?
|
| Documentation | 2 | 2022 | 115 | 0.230 |
Why?
|
| Infant | 16 | 2022 | 12302 | 0.220 |
Why?
|
| Child | 16 | 2023 | 24064 | 0.220 |
Why?
|
| Urologic Neoplasms | 1 | 2003 | 39 | 0.220 |
Why?
|
| Urinalysis | 1 | 2023 | 62 | 0.210 |
Why?
|
| Hydronephrosis | 3 | 2021 | 35 | 0.200 |
Why?
|
| Penile Diseases | 1 | 2020 | 11 | 0.180 |
Why?
|
| Humans | 38 | 2023 | 122296 | 0.180 |
Why?
|
| Urinary Fistula | 1 | 2020 | 20 | 0.180 |
Why?
|
| Cutaneous Fistula | 1 | 2020 | 22 | 0.180 |
Why?
|
| Hospitals, Pediatric | 3 | 2020 | 776 | 0.180 |
Why?
|
| Reoperation | 3 | 2020 | 807 | 0.180 |
Why?
|
| Child, Preschool | 13 | 2023 | 13777 | 0.170 |
Why?
|
| Urologic Surgical Procedures | 4 | 2021 | 58 | 0.170 |
Why?
|
| Anesthetics | 1 | 2020 | 81 | 0.170 |
Why?
|
| Nerve Block | 1 | 2020 | 68 | 0.170 |
Why?
|
| Male | 25 | 2020 | 59522 | 0.160 |
Why?
|
| Urogenital System | 1 | 2019 | 34 | 0.160 |
Why?
|
| Child Health | 1 | 2019 | 53 | 0.160 |
Why?
|
| Pediatricians | 1 | 2019 | 65 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2010 | 225 | 0.150 |
Why?
|
| Pediatrics | 2 | 2018 | 1140 | 0.150 |
Why?
|
| Equipment Design | 2 | 2018 | 596 | 0.150 |
Why?
|
| Physical Examination | 1 | 2019 | 163 | 0.150 |
Why?
|
| Physicians, Women | 1 | 2018 | 46 | 0.150 |
Why?
|
| Anesthesia | 1 | 2020 | 209 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 710 | 0.150 |
Why?
|
| Prostatic Diseases | 1 | 2017 | 14 | 0.140 |
Why?
|
| Engineering | 1 | 2017 | 5 | 0.140 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2016 | 18 | 0.140 |
Why?
|
| Treatment Outcome | 10 | 2023 | 12045 | 0.140 |
Why?
|
| Spermatic Cord Torsion | 1 | 2016 | 9 | 0.130 |
Why?
|
| Hematuria | 1 | 2016 | 50 | 0.130 |
Why?
|
| Cystitis | 1 | 2016 | 50 | 0.130 |
Why?
|
| Adolescent | 9 | 2023 | 18940 | 0.130 |
Why?
|
| Abscess | 1 | 2017 | 138 | 0.130 |
Why?
|
| Operating Rooms | 1 | 2016 | 69 | 0.130 |
Why?
|
| Specialties, Surgical | 1 | 2017 | 79 | 0.130 |
Why?
|
| Urethra | 1 | 2015 | 81 | 0.130 |
Why?
|
| Carbonic Anhydrases | 2 | 2006 | 25 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 268 | 0.130 |
Why?
|
| Injury Severity Score | 1 | 2016 | 213 | 0.130 |
Why?
|
| Anti-Retroviral Agents | 1 | 2016 | 135 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2022 | 691 | 0.130 |
Why?
|
| Foreskin | 1 | 2015 | 3 | 0.120 |
Why?
|
| Patient Transfer | 1 | 2016 | 101 | 0.120 |
Why?
|
| Hydrocolpos | 1 | 2014 | 2 | 0.120 |
Why?
|
| Treatment Failure | 1 | 2016 | 336 | 0.120 |
Why?
|
| Female | 19 | 2020 | 64883 | 0.120 |
Why?
|
| Infant, Newborn | 8 | 2018 | 8096 | 0.120 |
Why?
|
| Ureterocele | 1 | 2014 | 4 | 0.120 |
Why?
|
| Skin Transplantation | 1 | 2015 | 60 | 0.120 |
Why?
|
| Ureteroscopy | 1 | 2014 | 17 | 0.120 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 220 | 0.120 |
Why?
|
| Robotic Surgical Procedures | 1 | 2018 | 198 | 0.120 |
Why?
|
| Urogenital Abnormalities | 1 | 2016 | 163 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 635 | 0.110 |
Why?
|
| Bone Marrow Transplantation | 1 | 2016 | 581 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 2385 | 0.110 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 232 | 0.110 |
Why?
|
| Models, Animal | 2 | 2005 | 465 | 0.110 |
Why?
|
| Surgical Flaps | 1 | 2015 | 205 | 0.110 |
Why?
|
| Incidence | 5 | 2020 | 3018 | 0.100 |
Why?
|
| Ultrasonic Therapy | 2 | 2003 | 31 | 0.100 |
Why?
|
| Staphylococcal Infections | 1 | 2017 | 552 | 0.100 |
Why?
|
| Chromatography, Liquid | 2 | 2010 | 188 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 928 | 0.090 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2003 | 193 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2022 | 749 | 0.090 |
Why?
|
| Galactosemias | 1 | 2010 | 15 | 0.090 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2010 | 37 | 0.090 |
Why?
|
| Peroxisomal Disorders | 1 | 2010 | 13 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 1060 | 0.080 |
Why?
|
| Operative Time | 2 | 2020 | 158 | 0.080 |
Why?
|
| Steroid 11-beta-Hydroxylase | 1 | 2008 | 1 | 0.080 |
Why?
|
| Linear Models | 1 | 2010 | 657 | 0.070 |
Why?
|
| Androstenedione | 1 | 2007 | 10 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2016 | 3307 | 0.070 |
Why?
|
| Calibration | 1 | 2007 | 83 | 0.070 |
Why?
|
| Wound Healing | 2 | 2015 | 454 | 0.070 |
Why?
|
| False Positive Reactions | 1 | 2007 | 143 | 0.070 |
Why?
|
| Biliary Atresia | 1 | 2010 | 201 | 0.070 |
Why?
|
| Hydrocortisone | 1 | 2007 | 215 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 337 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3050 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2022 | 1158 | 0.060 |
Why?
|
| Kidney Calices | 1 | 2005 | 4 | 0.060 |
Why?
|
| Kidney Cortex | 1 | 2005 | 20 | 0.060 |
Why?
|
| Needles | 1 | 2005 | 52 | 0.060 |
Why?
|
| Hot Temperature | 1 | 2005 | 135 | 0.060 |
Why?
|
| Oxidoreductases | 1 | 2005 | 92 | 0.060 |
Why?
|
| Surgeons | 2 | 2020 | 244 | 0.060 |
Why?
|
| Adenocarcinoma, Clear Cell | 1 | 2004 | 24 | 0.060 |
Why?
|
| Necrosis | 1 | 2005 | 212 | 0.060 |
Why?
|
| Safety | 1 | 2005 | 217 | 0.060 |
Why?
|
| Dogs | 1 | 2005 | 761 | 0.060 |
Why?
|
| Time Factors | 2 | 2015 | 6182 | 0.060 |
Why?
|
| Prognosis | 5 | 2016 | 4488 | 0.060 |
Why?
|
| Cysts | 1 | 2004 | 99 | 0.060 |
Why?
|
| Tomography, Emission-Computed | 1 | 2003 | 43 | 0.060 |
Why?
|
| Syphilis, Congenital | 1 | 2003 | 28 | 0.050 |
Why?
|
| Survival Rate | 4 | 2016 | 1997 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2005 | 196 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2020 | 4643 | 0.050 |
Why?
|
| Quality Improvement | 2 | 2020 | 620 | 0.050 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2003 | 65 | 0.050 |
Why?
|
| Laser Therapy | 1 | 2005 | 245 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2003 | 287 | 0.050 |
Why?
|
| Cancer Vaccines | 1 | 2004 | 187 | 0.050 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 514 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 237 | 0.050 |
Why?
|
| Monocytes | 1 | 2004 | 347 | 0.050 |
Why?
|
| Swine | 1 | 2005 | 1157 | 0.050 |
Why?
|
| Fatty Acid Desaturases | 1 | 2001 | 8 | 0.050 |
Why?
|
| Infant, Premature | 1 | 2007 | 799 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2005 | 457 | 0.050 |
Why?
|
| Training Support | 1 | 2020 | 17 | 0.050 |
Why?
|
| Nurse Anesthetists | 1 | 2020 | 13 | 0.050 |
Why?
|
| Sacrococcygeal Region | 1 | 2020 | 32 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2004 | 637 | 0.050 |
Why?
|
| Anesthesia, Caudal | 1 | 2020 | 15 | 0.050 |
Why?
|
| Anesthesiologists | 1 | 2020 | 35 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 2796 | 0.040 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2001 | 104 | 0.040 |
Why?
|
| Neoplasm Staging | 4 | 2004 | 1227 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2003 | 446 | 0.040 |
Why?
|
| Pulmonary Alveoli | 1 | 2020 | 139 | 0.040 |
Why?
|
| United States | 3 | 2020 | 10487 | 0.040 |
Why?
|
| Genitalia, Male | 1 | 2019 | 38 | 0.040 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 428 | 0.040 |
Why?
|
| Patient Selection | 1 | 2003 | 685 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2022 | 376 | 0.040 |
Why?
|
| Recurrence | 2 | 2018 | 1413 | 0.040 |
Why?
|
| Dextrans | 1 | 2018 | 45 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 231 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2018 | 284 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2018 | 95 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 1424 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 1118 | 0.040 |
Why?
|
| Career Choice | 1 | 2018 | 143 | 0.040 |
Why?
|
| Texas | 2 | 2016 | 3528 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2018 | 151 | 0.040 |
Why?
|
| Administration, Intravesical | 1 | 2016 | 31 | 0.030 |
Why?
|
| Mentors | 1 | 2018 | 145 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 30 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2016 | 27 | 0.030 |
Why?
|
| Cystoscopy | 1 | 2016 | 44 | 0.030 |
Why?
|
| Cicatrix | 1 | 2018 | 125 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 5013 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2016 | 81 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2007 | 5963 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 4282 | 0.030 |
Why?
|
| Program Development | 1 | 2017 | 189 | 0.030 |
Why?
|
| Morbidity | 1 | 2016 | 239 | 0.030 |
Why?
|
| Animals | 3 | 2006 | 33721 | 0.030 |
Why?
|
| Mentoring | 1 | 2017 | 76 | 0.030 |
Why?
|
| Self Report | 1 | 2018 | 496 | 0.030 |
Why?
|
| Triage | 1 | 2016 | 141 | 0.030 |
Why?
|
| Colpotomy | 1 | 2014 | 6 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2003 | 1222 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 451 | 0.030 |
Why?
|
| Health Facilities | 1 | 2014 | 59 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 369 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2017 | 262 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 546 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 1615 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2003 | 1386 | 0.030 |
Why?
|
| Pedigree | 1 | 2016 | 1533 | 0.030 |
Why?
|
| Germany | 2 | 2003 | 86 | 0.030 |
Why?
|
| Risk Factors | 2 | 2016 | 9902 | 0.020 |
Why?
|
| Disease-Free Survival | 2 | 2004 | 872 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2016 | 1362 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2016 | 808 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2016 | 532 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2020 | 1153 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 1277 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 1991 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 803 | 0.020 |
Why?
|
| Middle Aged | 5 | 2005 | 25640 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2573 | 0.020 |
Why?
|
| Carbonic Anhydrase IX | 1 | 2006 | 15 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 979 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2004 | 21 | 0.010 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2003 | 14 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2004 | 204 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3448 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2004 | 321 | 0.010 |
Why?
|
| Aged | 3 | 2005 | 18785 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 8760 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 323 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 887 | 0.010 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2001 | 2 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 1104 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 810 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2003 | 382 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 1000 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2003 | 447 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2003 | 609 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 1468 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 1710 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2004 | 969 | 0.010 |
Why?
|
| Adult | 3 | 2005 | 28733 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2004 | 658 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 1272 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2004 | 3290 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 1575 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 1678 | 0.010 |
Why?
|
| Mass Screening | 1 | 2001 | 778 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 4151 | 0.010 |
Why?
|
| Mutation | 1 | 2008 | 5734 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 6291 | 0.010 |
Why?
|
| Mice | 1 | 2006 | 17546 | 0.010 |
Why?
|